A recent study reveals a significant rise in the number of adults in Ontario prescribed stimulants for ADHD since the onset of the COVID-19 pandemic, with women emerging as the predominant new users of these medications. The findings, published in the Canadian Medical Association Journal, highlight a shift in the demographic landscape of ADHD treatment, which has historically centred on younger males.
Study Highlights Dramatic Increase in Prescriptions
The research indicates that over 220,000 adults filled new prescriptions for stimulant medications, such as Vyvanse and Concerta, during the four years following March 2020. This figure represents a striking increase from approximately 107,000 prescriptions issued in the preceding four years. Initially, the onset of the pandemic saw a dramatic drop in new prescriptions as healthcare systems focused on COVID-19, but these numbers rebounded swiftly thereafter.
Mina Tadrous, a pharmacist and drug policy researcher at the University of Toronto, who contributed to the study, remarked on the rarity of such rapid growth in a well-established class of drugs. “We don’t often see this rapid of a growth in a drug class, especially one that has been around for so long,” she stated, urging a closer examination of this trend.
Women at the Forefront of New Diagnoses
The data reveals a notable gender shift among new stimulant users; women accounted for 59 per cent of adult prescriptions issued after the pandemic began, in contrast to 48 per cent in the pre-pandemic era. This change aligns with broader trends observed in ADHD diagnoses among adults, particularly female patients.
Daniel Myran, a research chair in family and community medicine at North York General Hospital, pointed out that many young adults have sought stimulant prescriptions following diagnoses from for-profit virtual care clinics. The study also noted a stark rise in prescriptions initiated through virtual consultations post-March 2020, with 29 per cent of new patients obtaining their medications this way, compared to almost none before the pandemic.
“This can be done very quickly from the comfort of your home,” Dr. Myran explained. However, he cautioned that this ease of access might lead to overdiagnosis, especially given the potential side effects associated with long-term stimulant use.
Factors Behind the Rise in Diagnoses
Several theories have emerged regarding the spike in adult ADHD diagnoses during the pandemic. Some researchers suggest that the shift to a screen-dominated lifestyle has exacerbated attention-deficit symptoms, while others highlight the role of social media, particularly TikTok, in increasing awareness of the disorder.
Emma Climie, a registered psychologist and associate professor at the University of Calgary, noted that many women in their 30s and 40s are now receiving ADHD diagnoses, often prompted by their children’s evaluations. The genetic predisposition of ADHD means that women may come to recognise their own symptoms as they see similar traits in their children.
Dr. Climie, along with her colleague Brandy Callahan, is conducting a long-term study focused on adult women with ADHD. She observed that some women find their coping mechanisms faltering under the pressures of balancing demanding careers and family responsibilities. “They’re burned out, they’re exhausted,” Dr. Climie explained. “They’re really struggling with, ‘Why does it look like everybody else has everything together? And I’m not able to do this?’”
The Risks of Overdiagnosis
While the increase in ADHD diagnoses presents an opportunity for many to receive much-needed support, there are inherent risks associated with the surge in prescriptions. Stimulants, while effective in improving attention and focus, come with potential side effects, including an increased risk of cardiovascular issues and the possibility of inducing manic episodes in individuals with underlying mental health conditions.
The concern is that the ease of virtual consultations might lead to hasty diagnoses. As ADHD becomes a more prominent topic of discussion, it is crucial that healthcare professionals approach the diagnosis and treatment process with care, ensuring that individuals receive the appropriate support without falling prey to overdiagnosis.
Why it Matters
Understanding the rise in ADHD diagnoses, particularly among women, is vital to addressing the complexities of mental health in contemporary society. As more individuals seek diagnosis and treatment, it is imperative for healthcare providers to maintain rigorous standards of care, balancing accessibility with the need for thorough assessment. The implications of this trend extend beyond individual health, signalling a shift in societal perceptions of ADHD and the importance of mental health awareness across diverse demographics. As we navigate this new landscape, fostering informed conversations around ADHD will be key to ensuring that those affected receive the appropriate recognition and support they deserve.
